Composite formulation for oral administration comprising ezetimibe and rosuvastatin
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 8, 2019
Grant Date -
Dec 1, 2016
app pub date -
Dec 30, 2014
filing date -
Dec 30, 2013
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Provided are a solid composite formulation for oral administration, the solid composite formulation including: an ezetimibe granules-part including ezetimibe, said ezetimibe having a particle size distribution wherein the average particle size d(0.9) for the bottom 90% is about 10 μm or less; and a rosuvastatin mixture-part including rosuvastatin or a pharmaceutically acceptable salt thereof, and a method of preparing the composite formulation.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully